Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation

British Journal of Haematology

Volumn 132, Issue 6, 2006, Pages 747-754

  Artz, Andrew S ^a,c   Kocherginsky, Masha ^b   Van Besien, Koen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Allogeneic transplant; Bias; clinical trial; Graft versus tumour; Reduced intensity conditioning; Renal cancer

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CARCINOMA, RENAL CELL; CLINICAL TRIALS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT SELECTION; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33644893074     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05923.x     Document Type: Article

References (30)

1. Artz A.S. Van Besien K. Zimmerman T. Gajewski T.F. Rini B.I. Hu H.S. Stadler W.M. Vogelzang N.J. 2005 Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience Bone Marrow Transplantation 35 253 260
2. Baron F. Frere P. Baudoux E. Sautois B. Fillet G. Beguin Y. 2003 Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma Haematologica 88 479 480
3. Blaise D. Bay J.O. Faucher C. Michallet M. Boiron J.M. Choufi B. Cahn J.Y. Gratecos N. Sotto J.J. Francois S. Fleury J. Mohty M. Chabannon C. Bilger K. Gravis G. Viret F. Braud A.C. Bardou V.J. Maraninchi D. Viens P. 2004 Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors Blood 103 435 441
4. Bregni M. Dodero A. Peccatori J. Pescarollo A. Bernardi M. Sassi I. Voena C. Zaniboni A. Bordignon C. Corradini P. 2002 Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer Blood 99 4234 4236
5. Castagna L. Bertuzzi A. Nozza A. Siracusano L. Balzarotti M. Magagnoli M. Sarina B. Timofeeva I. Sinnone M. Grimoldi M.G. Fare M. Santoro A. 2002 Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas Bone Marrow Transplantation 30 207 214
6. Childs R. Srinivasan R. 2002 Advances in allogeneic stem cell transplantation: directing graft-versus-leukemia at solid tumors Cancer Journal 8 2 11
7. Childs R. Chernoff A. Contentin N. Bahceci E. Schrump D. Leitman S. Read E.J. Tisdale J. Dunbar C. Linehan W.M. Young N.S. Barrett A.J. 2000 Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation New England Journal of Medicine 343 750 758
8. Citterio G. Bertuzzi A. Tresoldi M. Galli L. Di Lucca G. Scaglietti U. Rugarli C. 1997 Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients European Urology 31 286 291
9. Cochran W.G. 1954 Some methods for strengthening the common chi-square tests Biometrics 10 417 451
10. Fisher R.I. Rosenberg S.A. Sznol M. Parkinson D.R. Fyfe G. 1997 High-dose aldesleukin in renal cell carcinoma: long-term survival update The Cancer Journal from Scientific American 3 Suppl 1 70 72
11. Hentschke P. Barkholt L. Uzunel M. Mattsson J. Wersall P. Pisa P. Martola J. Albiin N. Wernerson A. Soderberg M. Remberger M. Thorne A. Ringden O. 2003 Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma Bone Marrow Transplantation 31 253 261
12. Huugen D. Bos G.M. Jansen M. Lalisang R. Jansen R. Wagstaff J. Schouten H.C. 2002 Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy Netherlands Journal of Medicine 60 170 173
13. Javidan J. Stricker H.J. Tamboli P. Amin M.B. Peabody J.O. Deshpande A. Menon M. 1999 Prognostic significance of the 1997 TNM classification of renal cell carcinoma Journal of Urology 162 1277 1281
14. Jemal A. Tiwari R.C. Murray T. Ghafoor A. Samuels A. Ward E. Feuer E.J. Thun M.J. 2004 Cancer statistics, 2004* CA: A Cancer Journal for Clinicians 54 8 29
15. Kalish L.A. Begg C.B. 1987 The impact of treatment allocation procedures on nominal significance levels and bias Controlled Clinical Trials 8 121 135
16. Karrison T.G. Huo D. Chappell R. 2003 A group sequential, response-adaptive design for randomized clinical trials Controlled Clinical Trials 24 506 522
17. Ljungberg B. Landberg G. Alamdari F.I. 2000 Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy Scandinavian Journal of Urology and Nephrology 34 246 251
18. Massenkeil G. Roigas J. Nagy M. Wille A. Stroszczynski C. Mapara M.Y. Loening S. Dorken B. Arnold R. 2004 Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity Bone Marrow Transplantation 34 309 316
19. Mejean A. Hopirtean V. Bazin J.P. Larousserie F. Benoit H. Chretien Y. Thiounn N. Dufour B. 2003 Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality Journal of Urology 170 764 767
20. Motzer R.J. Mazumdar M. Bacik J. Berg W. Amsterdam A. Ferrara J. 1999 Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma Journal of Clinical Oncology 17 2530 2540
21. Motzer R.J. Bacik J. Schwartz L.H. Reuter V. Russo P. Marion S. Mazumdar M. 2004 Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma Journal of Clinical Oncology 22 454 463
22. Naito S. Kimiya K. Sakamoto N. Soejima T. Ueda T. Kumazawa J. Osada Y. Kurozumi T. Sagiyama K. Ariyoshi A. 1991 Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma Urology 37 95 99
23. Nakagawa T. Kami M. Hori A. Kim S.W. Murashige N. Hamaki T. Kishi Y. Fujimoto H. Matsuoka N. Okajima E. Komiyama M. Tobisu K. Wakayama T. Uike N. Tajima K. Makimoto A. Mori S. Tanosaki R. Takaue Y. Kakizoe T. 2004 Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up Experimental Hematology 32 599 606
24. Pedrazzoli P. Da Prada G.A. Giorgiani G. Schiavo R. Zambelli A. Giraldi E. Landonio G. Locatelli F. Siena S. Della Cuna G.R. 2002 Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies Cancer 94 2409 2415
25. Rini B.I. Zimmerman T. Stadler W.M. Gajewski T.F. Vogelzang N.J. 2002 Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results Journal of Clinical Oncology 20 2017 2024
26. Rosenberg S.A. Yang J.C. Topalian S.L. Schwartzentruber D.J. Weber J.S. Parkinson D.R. Seipp C.A. Einhorn J.H. White D.E. 1994 Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2 The Journal of the American Medical Association 271 907 913
27. Therneau T. Grambsch P. 2000 Modeling Survival Data: Extending the Cox Model Springer-Verlag Inc. Berlin, New York
28. Tsui K.H. Shvarts O. Smith R.B. Figlin R.A. de Kernion J.B. Belldegrun A. 2000 Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria Journal of Urology 163 1090 1095
29. Tykodi S.S. Warren E.H. Thompson J.A. Riddell S.R. Childs R.W. Otterud B.E. Leppert M.F. Storb R. Sandmaier B.M. 2004 Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens Clinical Cancer Research 10 7799 7811
30. Ueno N.T. Cheng Y.C. Rondon G. Tannir N.M. Gajewski J.L. Couriel D.R. Hosing C. De Lima M.J. Anderlini P. Khouri I.F. Booser D.J. Hortobagyi G.N. Pagliaro L.C. Giralt S.A. Champlin R.E. 2003 Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem-cell transplantation for metastatic solid tumors Blood 102 3829 3836